References
- Sample Registration System, Maternal Mortality in India: 1997–2003. Trends, Causes and Risk Factors, Registrar General, New Delhi, India and Centre for Global Health Research, University of Toronto, Canada.
- Elbourne D R, Prendiville W J, Carroli G, Wood J, McDonald S. Prophylactic use of oxytocin in the third stage of labour. Cochrane Database Syst Rev 2001; CD001808
- National Neonatology Forum. State of India's Newborns. National Neonatology Forum, New Delhi, India 2004
- Sibley L, Ann Sipe T. What can a meta-analysis tell us about traditional birth attendant training and pregnancy outcomes?. Midwifery 2004; 20: 51–60
- Hofmeyr G J, Nikodem V C, de Jager M, Gelbart B R. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol 1998; 105: 971–975
- Bamigboye A A, Hofmeyr G J, Merrell D A. Rectal misoprostol in the prevention of postpartum hemorrhage: A placebo-controlled trial. Am J Obstet Gynecol 1998; 179: 1043–1046
- Bamigboye A A, Merrell D A, Hofmeyr G J, Mitchell R. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand 1998; 77: 178–181
- Derman R J, Kodkany B S, Goudar S S, Geller S E, Naik V A, Bellad M, Patted S S, Patel A, Edlavitch S A, Hartwell T, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: A randomised controlled trial. Lancet 2006; 368: 1248–1253
- Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, Sloan N. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: A randomised controlled trial. BJOG 2005; 112: 1277–1283
- Lalonde A, Daviss B A, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004–2006. Int J Gynaecol Obstet 2006; 94: 243–253
- Lumbiganon P, Hofmeyr J, Gulmezoglu A M, Pinol A, Villar J. Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour. Br J Obstet Gynaecol 1999; 106: 304–308
- Hofmeyr G J, Nikodem V C, de Jager M, Drakely A. Side-effects of oral misoprostol in the third stage of labour – a randomised placebo-controlled trial. S Afr Med J 2001; 91: 432–435
- Lumbiganon P, Villar J, Piaggio G, Gulmezoglu A M, Adetoro L, Carroli G. Side effects of oral misoprostol during the first 24 h after administration in the third stage of labour. BJOG 2002; 109: 1222–1226
- el-Refaey H, O'Brien P, Morafa W, Walder J, Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. BJOG 1997; 104: 336–339
- Hofmeyr G J, Walraven G, Gulmezoglu A M, Maholwana B, Alfirevic Z, Villar J. Misoprostol to treat postpartum haemorrhage: A systematic review. Br J Obstet Gynaecol 2005; 112: 547–553
- el-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: A randomized comparison between two misoprostol regimens. Hum Reprod 1995; 10: 475–478
- Khan R U, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003; 101: 968–974
- Abdel-Aleem H, Villar J, Gulmezoglu A M, Mostafa S A, Youssef A A, Shokry M, Watzer B. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol 2003; 108: 25–28
- Gulmezoglu A M, Villar J, Ngoc N T, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr G, Lumbiganon P, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001; 358: 689–695
- Daisley H, Jr. Maternal mortality following the use of misoprostol. Med Sci Law 2000; 40: 78–82